Welcome on the webpage of the project “Promotion and facilitation of international cooperation with Eastern European and Central Asian Countries” (the “EECAlink”).
The project was funded by the European Commission under Grant Agreement No. 223359 as a Coordination and Support Action, priority Health.
Brussels, 9-10 February 2012
European Commission, Charlemagne Building, Rue de la Loi 170, Brussels
Diabetes - a ticking time bomb
Diabetes causes severe health complications and is the fifth leading cause of death world-wide. The number of persons suffering from the "type 2" form of this disease is set to rise to some 900 million globally by 2030, with devastating health and economic implications. To counter this sinister scenario, increasing attention is given to research into the environmental and genetic risk factors for diabetes and obesity in specific populations.
Meet international key players in the field
Organised by the European Commission, this conference will bring together
• Leading scientists in the field from across the globe
• National funding agencies from different parts of the world
• National, European and international policy-makers
• Other key players in the field
Be a part of new international co-operation and partnerships
Under its current Research Framework Programme, the European Union supports a series of major scientific projects to better understand and combat type-2 diabetes. Each project focuses on a different region of the world. The conference will take this global approach further by presenting the state of play and by exploring opportunities for even greater international cooperation and new partnerships.
Find more details on the event and registration modalities at the conference website:
http://ec.europa.eu/research/health/events-12_en.html
An event entitled 'New opportunities for drug research in Europe' will take place on 12 November 2011 in Krakow, Poland.
Conference attendees will be able to learn how Innovative Medicines Initiative (IMI) works and hear about participating in the project. Discussions will also centre on the benefits and opportunities offered by IMI to researchers in Poland and elsewhere. There will also be a networking session at the close of the conference.
The Innovative Medicines Initiative is a public-private partnership whose mission is to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. IMI also supports collaborative research projects and builds networks of industrial and academic experts in Europe.
The half-day event will take place at the same time as the Congress of Polish Biotechnology and the Central European Congress of Life Sciences.
For further information, please visit: here
A conference on regenerative medicine will take place from 2 to 4 November 2011 in Leipzig, Germany.
Regenerative medicine is a research-intensive branch of medicine. Progress in the laboratory is often translated into clinical reality by teams of natural scientists, human and veterinary medical scientists all working together.
The event will be an opportunity for researchers to exchange views on the latest developments and bring together the stakeholder community. Young scientists and PhD students will have the chance to present their current research works. The conference will also gather leaders of companies involved in transforming research into cell and tissue engineered products.
For further information, please visit: http://www.wcrm-leipzig.com/topics.php
BIOTECHNICA is Europe's leading annual event for biotechnology and the life sciences, covering all topics from Bioprocess Technology and Bio-Engineering, Bioinformatics, Bioanalytics to Biotech Services and Biotech Applications.
During the BIOTECHNICA 2011 in Hannover, Germany the European initiative “Fit for Health” (www.fitforhealth.eu) is organizing two different events for scientists and managers in SMEs, research institutes, universities, hospitals in the fields of health, life sciences, genomic, biotechnology and pharmacy:
1. International Workshop “Valorisation of FP7 R&D Results” on October 11, 2011 at Hannover Messe.
2. BioBusinessMatching 2011 on October 12-13, 2011 at Hannover Messe, Hall 9.
On 20 July 2011, two Framework Programme 7 (FP7) HEALTH calls were published on Research Participant Portal, which is now the European Commission's single authoritative webpage for FP7 calls.
Information about the calls can be found on following adresses:
FP7-HEALTH-2012-INNOVATION:
FP7-HEALTH-2012-SMES-FOR-INNOVATION:
On February 1st 2011 the EECAlink National Policy Session in Armenia took place at National Academy of Sciences in Yerevan. The aim of this session was was to identify gaps and overlaps between FP7 Health and Armenian research priorities, as well as outline Health research topics for mutually beneficial international cooperation.
The Policy Session was attended by 13 participants, including national experts representing Yerevan State Medical University, National Institute of Health of the Ministry of Healthcare of Armenia, various research institutes of the National Academy of Sciences involved in health research. The meeting was attended by Dr. Gianpietro van de Goor, Senior Policy Officer, International Cooperation in Health Research, European Commission, who presented FP7 Health research priorities and opportunities for international cooperation. The policy session was concluded by a general discussion on health research topics for mutually beneficial cooperation. As a result of the discussion possible areas of cooperation were mentioned to be Familial Mediterranean Fever as rare disease, cancer, cardiovascular diseases and diabetes.
Presentations and more photos are available at:
http://nip.sci.am/content/news26.htm
This website includes all projects related to life science and health supported by the European Commission since 2004. It gives visibility to organisations and scientists involved in these projects and, together with interactive search devices, facilitates the identification of potential collaboration partners and the set up of partnerships between academia and industry in health research.
HealthCompetence will also progressively give access to the research results in terms of technology offers, patents and publications.
http://www.healthcompetence.eu/converis/publicweb/area/1353
Are you a Small and Medium sized Enterprise (SME) interested in strengthening your market position, improving your existing products or acquiring new skills by getting involved in a Research and Development (R&D) project funded by the European Commission (EC)? If so, we can help you to get the most out of your R&D project. Alternatively, if you are a research performer currently working in a project with SMEs, or considering doing so in the future, then this Guide will also be of use to you.
@2009, EECA link